# The Role of the Coagulation Pathways in Recurrent Angioedema

> **NCT02892682** · NA · TERMINATED · sponsor: **University Hospital, Montpellier** · enrollment: 96 (actual)

## Conditions studied

- Chronic Spotaneous Urticaria, Idiopathic Non Histaminergic Angioderma, Hereditary Angioedema With C1 Inhibitor Deficiency

## Interventions

- **OTHER:** BLOOD TEST

## Key facts

- **NCT ID:** NCT02892682
- **Lead sponsor:** University Hospital, Montpellier
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2016-05-31
- **Primary completion:** 2023-05-10
- **Final completion:** 2023-05-10
- **Target enrollment:** 96 (ACTUAL)
- **Why stopped:** no more inclusion
- **Last updated:** 2023-12-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02892682

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02892682, "The Role of the Coagulation Pathways in Recurrent Angioedema". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02892682. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*